Clinical Trial Update: Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response [Phase 2]

View source ↗

Summary

Phase 2 trial exploring pre-diltiazem calcium versus placebo for atrial fibrillation with rapid ventricular response, status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation with Rapid Ventricular Response
• Hypotension

Drugs mentioned

• pre-diltiazem (pre-diltiazem)

Snippet

Sponsor: Ascension Health | Conditions: Atrial Fibrillation With Rapid Ventricular Response, Hypotension | Phase 2 | Status: UNKNOWN